Delivery Order SPE2DB22D1106-SPE2DB25FELM9
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $6,312.96, is for a delivery order of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of December 23, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (DO) valued at $2,912.78 issued by the Defense Logistics Agency (DLA). The award is for the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, which is a medical supply for use by the U.S. government. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,616.87 Firm Fixed Price Delivery Order is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 6, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $1,903.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, designated as SPE2DB20D1100|SPE2DB25FB9B5, is a delivery order contract for the supply of the pharmaceutical product "KONVOMEP 2-84 MG/ML ORAL SUSP 300ML". The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, with a ceiling value of $2,040.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order for the supply of the drug KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, with a completion date of June 23, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,042.18, is a Firm Fixed Price Delivery Order to provide KONVOMEP 2-84 MG/ML ORAL SUSP 90ML, a pharmaceutical product. The award has an ultimate completion date of December 10, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This federal contract award, valued at $1,401.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract, with a firm fixed price pricing type, and an ultimate completion date of December 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $1,086,340.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for a firm fixed price and has an ultimate completion date of June 17, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for $1,164.26. The contract, with an ultimate completion date of October 30, 2024, is a Firm Fixed Price agreement with the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $65,381.46, is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of January 28, 2025. The award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...